The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells
- PMID: 27035814
- PMCID: PMC4811160
- DOI: 10.1172/JCI87345
The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells
Retraction of
-
The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells.J Clin Invest. 2005 Apr;115(4):1068-81. doi: 10.1172/JCI22758. Epub 2005 Mar 10. J Clin Invest. 2005. Retraction in: J Clin Invest. 2016 Apr 1;126(4):1603. doi: 10.1172/JCI87345. PMID: 15761501 Free PMC article. Retracted.
Similar articles
-
The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells.J Clin Invest. 2005 Apr;115(4):1068-81. doi: 10.1172/JCI22758. Epub 2005 Mar 10. J Clin Invest. 2005. Retraction in: J Clin Invest. 2016 Apr 1;126(4):1603. doi: 10.1172/JCI87345. PMID: 15761501 Free PMC article. Retracted.
-
BRAF mediates RET/PTC-induced mitogen-activated protein kinase activation in thyroid cells: functional support for requirement of the RET/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesis.Endocrinology. 2006 Feb;147(2):1014-9. doi: 10.1210/en.2005-0280. Epub 2005 Oct 27. Endocrinology. 2006. PMID: 16254036
-
High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.Cancer Res. 2003 Aug 1;63(15):4561-7. Cancer Res. 2003. PMID: 12907632
-
Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.Cancer. 2005 Jun 1;103(11):2261-8. doi: 10.1002/cncr.21073. Cancer. 2005. PMID: 15880523 Review.
-
BRAF mutations in papillary thyroid carcinoma.Endocr Regul. 2006 Dec;40(4):129-38. Endocr Regul. 2006. PMID: 17201587 Review.
Cited by
-
Tumor-associated macrophages as a potential therapeutic target in thyroid cancers.Cancer Immunol Immunother. 2023 Dec;72(12):3895-3917. doi: 10.1007/s00262-023-03549-6. Epub 2023 Oct 5. Cancer Immunol Immunother. 2023. PMID: 37796300 Free PMC article. Review.
-
Coexisting CLT in PTC is an independent predictor of tumor aggressiveness for patients aged under 55: a retrospective analysis of 635 patients.BMC Endocr Disord. 2022 Mar 7;22(1):55. doi: 10.1186/s12902-022-00945-4. BMC Endocr Disord. 2022. PMID: 35255870 Free PMC article.
-
Chasing the Target: New Phenomena of Resistance to Novel Selective RET Inhibitors in Lung Cancer. Updated Evidence and Future Perspectives.Cancers (Basel). 2021 Mar 4;13(5):1091. doi: 10.3390/cancers13051091. Cancers (Basel). 2021. PMID: 33806299 Free PMC article. Review.
-
On zombie papers.Cell Death Dis. 2019 Feb 25;10(3):189. doi: 10.1038/s41419-019-1450-3. Cell Death Dis. 2019. PMID: 30804342 Free PMC article. No abstract available.
-
Association of microRNA-related gene XPO5 rs11077 polymorphism with susceptibility to thyroid cancer.Medicine (Baltimore). 2017 Apr;96(14):e6351. doi: 10.1097/MD.0000000000006351. Medicine (Baltimore). 2017. PMID: 28383405 Free PMC article.
References
-
- Melillo RM, et al. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma. Am J Pathol. 2004;165(2):511–521. doi: 10.1016/S0002-9440(10)63316-0. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
